* © Quick-Med Technologies, Inc. Proprietary www.quickmedtech.com Scientific Team Bernd Liesenfeld, Ph.D President Joined in 2004. Led the development of the Nimbus technology used the Bioguard line of products licensed to Derma Science. Has been involved in all aspects of commercializing Quick-Med’s antimicrobial technologies including biochemistry, regulatory and production development. William Toreki, Ph.D VP, Research & Development Joined in 2002. Served as QMT’s Chief Scientist . An experienced researcher and inventor with 20 granted US patents. Responsible for the development of StayFresh®, Nimbus®, and NimbuDerm™ antimicrobial technologies. Jerry Olderman, Ph.D Director & Scientific Advisor Joined in 1997. 45 years of healthcare, and R&D experience. C.R. Bard’s Cardiopulmonary Division – Director of R&D; Baxter Healthcare – VP, R&D Pharmaseal Division; Surgikos, VP R&D. PhD, Physical Chemistry, Seton Hall Greg Shultz, Ph.D. Director & Scientific Advisor Professor of Obstetrics/Gynecology and Director of the Institute for Wound Research, College of Medicine at the University of Florida. Past President, Wound Healing Society (1999-2001), PhD Biochemistry, Oklahoma State Univ. Post-doc Cell Biology, Yale Chris Batich, Ph.D. Scientific Advisor Professor of Biomedical Engineering, and associate Director, Clinical and Translational Science Institute, University of Florida. PhD Organic Chemistry, Rutgers. Post-doc Physical Chemistry, Univ. of Basel